There are 97 papers on frailty in aging research: 5 trials and 70 observational studies in people, 20 reviews.
778 new papers in 30 daysSee all 24,709 papers on frailty
“pre-frail/frail (n = 336) of 3.06, and CF of 30.61 for having CF at 2 years”
- Human trial5
- Humans70
- In silico2
Interventions
13Aerobic exercise
downin humans1
1 study
Aerobic exercise
downin humans1
Aerobic exercise decreases frailty in humans during daycare rehabilitation.
Human trialduring daycare rehabilitationseated stepping and arm movements at 120 bpm for two 2-minute setstwo 2-minute sets6 monthsn = 252
Renal rehabilitation
downin humans1
1 study
Renal rehabilitation
downin humans1
Renal rehabilitation decreases frailty in humans (maintenance hemodialysis).
Reviewmaintenance hemodialysis
Exercise
downin humans1
1 study
Exercise
downin humans1
Exercise prevents frailty in humans (pre-frailty).
Reviewpre-frailty
Health promotion training
downin humans1
1 study
Health promotion training
downin humans1
Health promotion training decreases frailty in humans (older family caregivers with frailty) (d = 1.3-1.8).
Human trialolder family caregivers with frailtystructured three sessionsthree sessionsn = 75
High body mass index
no changein humans1
1 study
High body mass index
no changein humans1
High body mass index was not clearly linked with frailty in humans (compared with BMI 21.5-24.9 kg/m2 group) (β = -0.01, SE = 0.06).
Humanscompared with BMI 21.5-24.9 kg/m2 group≥ 25.0 kg/m23-yearn = 515
Sensorimotor training
downin humans1
1 study
Sensorimotor training
downin humans1
Sensorimotor training decreases frailty in humans after 60 days of training; time-by-group interaction a trend (p = 0.058) (EG p < 0.001 vs CG p = 0.039).
Human trialafter 60 days of training; time-by-group interaction a trend (p = 0.058)tablet appdaily 30 min sessions60 daysn = 48
Aerobic steps/day
downin humans1
1 study
Aerobic steps/day
downin humans1
Aerobic steps/day is linked with lower frailty in humans across categories of aerobic steps/day (cross-sectional prevalence).
Humansacross categories of aerobic steps/day (cross-sectional prevalence)n = 427
Total steps/day
downin humans1
1 study
Total steps/day
downin humans1
Total steps/day is linked with lower frailty in humans across categories of total steps/day (cross-sectional prevalence).
Humansacross categories of total steps/day (cross-sectional prevalence)n = 427
Physical activity
downin humans1
1 study
Physical activity
downin humans1
Physical activity prevents frailty in humans (pooled standardized mean difference 0.24; 95% CI 0.04-0.43; P = .017).
Review
Poor social network
no changein humans1HR 0.92
1 study
Poor social network
no changein humans1HR 0.92
Poor social network was not clearly linked with frailty in humans (poor social network vs better social network) (HR 0.92 (95% CI 0.74–1.15)).
Humanspoor social network vs better social network11-year follow-upmensn = 22,226
Goal-setting
downin humans1
1 study
Goal-setting
downin humans1
Goal-setting decreases frailty in community-dwelling frail older people receiving preventive care exercise classes (approximately 60 % vs 40 %).
Human trialin community-dwelling frail older people receiving preventive care exercise classes9 monthsn = 176
All 13Fewer
Effects
56Quality of life
downin humans4
4 studies
Quality of life
downin humans4
Frailty is linked with worse quality of life in humans.
Humansn = 257
Frailty is linked with worse quality of life in humans (KCCQ 35 ± 19 vs. 46 ± 21).
Humans
Frailty impairs quality of life in patients with COPD, IPF and asthma.
Reviewin patients with COPD, IPF and asthma
Frailty impairs quality of life in humans (community-dwelling older people) (medium or larger SMDs for 24 of 31 QOL scales).
Reviewcommunity-dwelling older peoplen = 24,419
Health-related quality of life
downin humans3
3 studies
Health-related quality of life
downin humans3
Frailty is linked with lower health-related quality of life in humans (colorectal cancer).
Humanscolorectal cancern = 142
Frailty is linked with worse health-related quality of life in humans (compared to patients at-risk of malnutrition) (coefficient -0.08, 95% -0.0132--0.031, p=0.002).
Humanscompared to patients at-risk of malnutritionn = 263
Frailty is linked with lower health-related quality of life in humans (-0.10 (95%CI -0.17; -0.02) on EQ-5D-5L index, about 10% reduction of the maximum index).
Humansadjusted for socioeconomic, behavioral, health status and healthcare utilization covariates; frail versus non-frail groupsn = 523
Cognitive function
downin humans1no changein humans1
2 studies
Cognitive function
downin humans1no changein humans1
Frailty is linked with worse cognitive function in late-life depression patients.
Humansin late-life depression patients
Frailty was not clearly linked with cognitive function in humans.
Humans
Neutrophil extracellular traps
upin humans2
2 studies
Neutrophil extracellular traps
upin humans2
Frailty is linked with higher neutrophil extracellular traps in response to LPS.
Humansin response to LPS10 ng/ml
Frailty is linked with higher neutrophil extracellular traps in response to LPS (10ng/mL) compared to healthy older individuals.
Humansin response to LPS (10ng/mL) compared to healthy older individualsneutrophils10ng/mL
Inflammation
upin humans2
2 studies
Inflammation
upin humans2
Frailty is linked with higher inflammation in monocytes of frail elderly individuals.
Humansin monocytes of frail elderly individualsperipheral blood mononuclear cells
Frailty is linked with higher inflammation in combination with trauma.
Humansin combination with trauman = 100
Physical function
downin humans2
2 studies
Physical function
downin humans2
Frailty is linked with worse physical function in humans (SPPB 5 ± 2.2 vs. 7 ± 2.4).
Humans
Frailty is linked with lower physical function in nursing home residents with frailty (-9.54 points per year, score at death 77.1, CI [73.8, 80.9]).
Humansin nursing home residents with frailty
Hospitalization
downin humans1upin humans1
1 study
Hospitalization
downin humans1upin humans1
Frailty is linked with lower hospitalization in humans (most frail versus nonfrail residents, FRAIL-NH) (IRR 0.65 (95% CI 0.42-0.99)).
Humansmost frail versus nonfrail residents, FRAIL-NH12 months
Frailty is linked with higher hospitalization in humans (mild/moderate versus nonfrail residents, FRAIL-NH) (adjusted IRR 1.57 (95% CI 1.11-2.20)).
Humansmild/moderate versus nonfrail residents, FRAIL-NH12 months
Grip strength
downin humans1
1 study
Grip strength
downin humans1
Frailty is linked with worse grip strength in maintenance hemodialysis patients (18.00 [13.60-22.60] kg vs 26.70 [20.90-30.20] kg, p < 0.001).
Humansin maintenance hemodialysis patientsn = 66
PD-1
upin humans1
1 study
PD-1
upin humans1
Frailty is linked with higher PD-1 in humans (Vγ9Vδ2 T cells from frail versus non-frail older adults) (approximately two-fold higher).
HumansVγ9Vδ2 T cells from frail versus non-frail older adults
CD69
downin humans1
1 study
CD69
downin humans1
Frailty is linked with lower CD69 in humans (Vγ9Vδ2 T cells from frail versus non-frail older adults) (approximately one-third lower).
HumansVγ9Vδ2 T cells from frail versus non-frail older adults
All 56Fewer
Upstream
5Cognitive function
mediatesin humans1
1 study
Cognitive function
mediatesin humans1
Cognitive function is linked with frailty in humans (mediation of the physical activity–frailty association) (indirect effect -0.01 (95% CI -0.02 to -0.01), 8.37% of total effect).
Humansmediation of the physical activity–frailty association
Biological changes of aging
mediatesin reviews1
1 study
Biological changes of aging
mediatesin reviews1
biological changes of aging mediates frailty.
Review
Inflammation
upin humans1
1 study
Inflammation
upin humans1
Inflammation increases frailty in humans.
Review
Population aging
upin humans1
1 study
Population aging
upin humans1
Population aging increases frailty in humans.
Review
Appendicular skeletal muscle mass
no changein humans1
1 study
Appendicular skeletal muscle mass
no changein humans1
Appendicular skeletal muscle mass was not clearly linked with frailty in humans (direct effect; indirect effect via grip strength).
Humansdirect effect; indirect effect via grip strengthn = 997
Associations
280Mortality
upin humans33RR 2.04–2.41
33 studies
Mortality
upin humans33RR 2.04–2.41
Frailty is linked with a higher risk of mortality in humans (frail with MVPA <150 min/week vs robust people with the highest MVPA level) (~6 times higher risk).
Humansfrail with MVPA <150 min/week vs robust people with the highest MVPA levelMVPA <150 min/week
Frailty is linked with a higher risk of mortality in humans (mild, moderate and severe frailty vs fit (reference)) (adjusted HR 1.36 mild, 2.19 moderate, 4.29 severe).
Humansmild, moderate and severe frailty vs fit (reference)n = 893,211
Frailty predicts mortality in humans (stratified by age and SOFA score in hospitalized COVID-19).
Humansstratified by age and SOFA score in hospitalized COVID-19
Frailty is linked with a higher risk of mortality in humans (severe frailty to terminally ill vs fit-to-manage-well, adjusted, hospitalized COVID-19) (HR 2.3 (1.8-2.9) at 6 months; HR 2.1 (1.6-2.7) at 30 days).
Humanssevere frailty to terminally ill vs fit-to-manage-well, adjusted, hospitalized COVID-196 months
Frailty is linked with a higher risk of mortality in humans (frailty combined with ≥2 other conditions versus no conditions) (HR 4.96 (95% CI 2.73 to 9.01)).
Humansfrailty combined with ≥2 other conditions versus no conditions
Frailty is linked with a higher risk of mortality in humans (HR 1.4, 95% CI 1.03-2.6).
Humansmultivariate Cox regression adjusted for age, sex, malnutrition, low muscle mass, number of chronic diseases and regular medicationsmedian follow-up of 46 monthsn = 224
Frailty is linked with a higher risk of mortality in humans (frailty only, without sarcopenia, multivariable model) (HR 2.03).
Humansfrailty only, without sarcopenia, multivariable modelminimum of 10 years follow-upn = 716
Frailty is linked with a higher risk of mortality in humans (frailty defined as PRISMA-7 score ≥3 in hospital patients aged 75+) (OR 2.46, 95% CI 1.53 to 3.97).
Humansfrailty defined as PRISMA-7 score ≥3 in hospital patients aged 75+1 yearn = 973
Frailty is linked with a higher risk of mortality in humans (aRR 6.81 (95% CI 6.50–7.13) for severe frailty within the polypharmacy group).
Humansdose-response across frailty categories within the polypharmacy group; severe frailty shown
Frailty predicts mortality in humans (frailty identified in 2014, deaths in 2015) (27% (BC) and 14% (MB) died in 2015).
Humansfrailty identified in 2014, deaths in 2015one year
All 34Fewer
Depression
upin humans5
5 studies
Depression
upin humans5
Depression is associated with frailty in humans (multivariable linear regression) (B = 0.306, p = 0.011).
Humansmultivariable linear regressionfemales
Frailty is associated with depression in humans (β = 0.272, P < 0.001).
Humansn = 1,789
Frailty is associated with depression in humans (r = 0.093, P = 0.046).
Humansn = 663
Frailty is associated with depression in humans (GDS 5.5 ± 3.5 vs. 4.2 ± 3.3).
Humans
Depression raises the risk of frailty in humans.
Review
Sarcopenia
upin humans4no changein reviews1+97%OR 1.91
5 studies
Sarcopenia
upin humans4no changein reviews1+97%OR 1.91
Frailty is associated with sarcopenia in humans (older outpatients with diabetes mellitus) (96.6%).
Humansolder outpatients with diabetes mellitusn = 122
Frailty predicts sarcopenia in humans (OR 1.91 (95% CI 1.313-2.766)).
Humans
Sarcopenia is associated with frailty in humans (combined in 80 (18%) patients).
Humans
Sarcopenia is associated with frailty in humans (geriatric outpatients).
Humansgeriatric outpatients
Frailty is associated with sarcopenia.
Review
C-reactive protein
upin humans5
5 studies
C-reactive protein
upin humans5
C-reactive protein is associated with frailty in humans (higher plasma levels in frail than non-frail subjects; IL-1β, IL-6 and TNFα also raised).
Humanshigher plasma levels in frail than non-frail subjects; IL-1β, IL-6 and TNFα also raisedplasma
Frailty is associated with C-reactive protein in patients with symptomatic severe aortic valve stenosis before TAVI (3.7 (1.4-5.4) vs 5.9 (3.7-29.1)).
Humansin patients with symptomatic severe aortic valve stenosis before TAVI
C-reactive protein is associated with frailty in humans after adjustment for age.
Humansafter adjustment for agen = 141
C-reactive protein is associated with frailty in humans (frail vs robust) (SMD 0.49 (95% CI 0.37–0.61)).
Humansfrail vs robustplasma
Frailty is associated with C-reactive protein in humans (frail vs healthy group).
Humansfrail vs healthy groupplasma>15 yearsn = 289
Disability
upin humans3upin reviews1OR 1.3–1.8
4 studies
Disability
upin humans3upin reviews1OR 1.3–1.8
Frailty is linked with a higher risk of disability in humans (adjusted for age, gender, medical comorbidity and the two other frailty dimensions) (OR 1.3-1.8 (functional disability); OR 2.2-7.3 (severe disability)).
Humansadjusted for age, gender, medical comorbidity and the two other frailty dimensionsn = 2,387
Frailty is linked with a higher risk of disability in humans (community-dwelling elders; compared with non-frailty) (RR 2.53 (95% CI 2.01-3.14)).
Humanscommunity-dwelling elders; compared with non-frailtyn = 88,906
Frailty predicts disability in humans.
Review
Frailty is associated with disability (frailty instruments containing ADL items) (52.1% of 217 instruments included ADL items).
Reviewfrailty instruments containing ADL items
Depressive symptoms
upin humans3
3 studies
Depressive symptoms
upin humans3
Frailty is associated with depressive symptoms in humans (cross-sectional association).
Humanscross-sectional associationn = 667
Depressive symptoms are associated with frailty in humans (adults aged ≥75 years; 3-year follow-up).
Humansadults aged ≥75 years; 3-year follow-up3 yearsn = 569
Depressive symptoms predict frailty in humans (prospective, previous CES-D score predicting current frailty).
Humansprospective, previous CES-D score predicting current frailty
Frailty predicts depressive symptoms in humans (prospective, previous frailty predicting current CES-D score).
Humansprospective, previous frailty predicting current CES-D score
30-day mortality
upin humans3OR 3.28–10.07
3 studies
30-day mortality
upin humans3OR 3.28–10.07
Frailty is associated with 30-day mortality in humans (IRR 1.08 (95% CI 1.06-1.10)).
Humansper 1-point increase in Clinical Frailty Scale, adjusted for age, sex, Sequential Organ Failure Assessment score, organ support and treatment limitations
Sex linked to a small mortality gap in older intensive care adults
European journal of internal medicineFrailty is linked with a higher risk of 30-day mortality in humans (frailty defined as SPPB < 5) (17.6% vs. 2.1%; OR 10.07 (95% CI 1.5-67.5)).
Humansfrailty defined as SPPB < 530 days
Frailty is linked with a higher risk of 30-day mortality in humans (older patients hospitalized with acute coronary syndrome; multivariate logistic regression) (adjusted OR 3.28, 95% CI 1.59-6.76).
Humansolder patients hospitalized with acute coronary syndrome; multivariate logistic regression30 days
Inflammation
upin humans2upin silico1
3 studies
Inflammation
upin humans2upin silico1
Inflammation is associated with frailty in humans.
Review
Inflammation is associated with frailty in humans.
Review
Inflammation is associated with frailty in silico.
In silico
Hospitalization
upin humans3HR 1.94
3 studies
Hospitalization
upin humans3HR 1.94
Frailty is linked with a higher risk of hospitalization in humans (OR = 1.38 (95% CI 1.03-1.85) pre-frail; OR = 2.79 (95% CI 1.89-4.12) frail).
Humansonline FRAIL scale assessment at baseline, controlled for age, sex, marital status, and educational level2 yearsn = 1,882
Frailty is linked with a higher risk of hospitalization in humans (OR 1.93 (95% CI 1.00-3.72)).
Humansfrailty by Fried Frailty Index screening; logistic regression adjusted for relevant confounders6 months
Frailty raises the risk of hospitalization in humans (pooled HR 1.94 (95% CI: 1.17-3.24)).
Review
Death
upin humans2upin reviews1OR 4.08
3 studies
Death
upin humans2upin reviews1OR 4.08
Frailty is linked with a higher risk of death in humans (Spanish community-dwelling older adults) (OR 4.08 [1.97-8.43]).
HumansSpanish community-dwelling older adults3.5 years
Frailty predicts death in humans.
Review
Frailty raises the risk of death in response to minor stressors.
Reviewin response to minor stressors
Cognitive frailty
upin humans1RR 3.06
1 study
Cognitive frailty
upin humans1RR 3.06
Frailty raises the risk of cognitive frailty in humans (RR 3.06).
Human trial2 yearsn = 336
Combined exercise or walking program
mixedin humans1
1 study
Combined exercise or walking program
mixedin humans1
Combined exercise or walking program is associated with frailty in humans (combined exercise, walking program, or no intervention groups).
Human trialcombined exercise, walking program, or no intervention groups10 weeksn = 103
Combined physical and cognitive training
downin humans1
1 study
Combined physical and cognitive training
downin humans1
Combined physical and cognitive training lowers the risk of frailty in humans (older people with mild cognitive impairment) (twice the risk in controls versus active group).
Human trialolder people with mild cognitive impairmentone year
All 280Fewer
Trial sponsors
Company1 trialPhase 260 people
Company1 trialPhase 1/265 people
Company1 trialPhase 1/212 people
Company1 trialPhase 112 people
Company1 trial318 people
Company1 trial39 people
Company1 trial26 people
2 trialsPhase 4248 people
Funding
759 grants since 2016Japan Society for the Promotion of Science¥2.32BNational Institute on Aging$86MGouvernement du Canada | Canadian Institutes of Health ResearchCA$29.1M
Frailty and Influenza Vaccination Among Older Adults
US Department of Veterans AffairsVA Greater Los Angeles Healthcare System2024–2029
Lifestyle Intervention plus Metformin to Treat Frailty in Older Veterans with Obesity
US Department of Veterans AffairsMichael E. DeBakey VA Medical Center2020–2026
Frailty and Resiliency in Older Adults with Acute Myocardial Infarction
National Heart, Lung, and Blood InstituteCleveland Clinic Lerner Com-cwru$183K2020–2027
XFIT: An Exercise-based Frailty Intervention in Lung Transplant Candidates
National Heart, Lung, and Blood InstituteUniversity of California, San Francisco$777K2024–2029
National Cancer InstituteUniversity of Maryland Baltimore$638K2026–2031
National Institute on AgingVanderbilt University Medical Center$75.6K2025–2030
Machine learning based frailty index for the genetically diverse mice
National Institute on AgingThe Jackson Laboratory$667K2022–2027
Skin immunity as a function of frailty, aging, and skin microbiome composition
National Institute on AgingDuke University$447K2024–2029
National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of California, San Francisco$702K2023–2028
National Institute on AgingCedars-Sinai Medical Center$1.5M2025–2030